Assessment of Mandibular Osseous Changes in Patients With End Stage Renal Failure
NCT ID: NCT03162029
Last Updated: 2017-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
26 participants
OBSERVATIONAL
2017-08-31
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Accuracy and Reliability of Ultra Low Dose CBCT Versus CBCT Imaging in Semi-automated Segmentation of the Mandibular Condyle (A Diagnostic Accuracy Study)
NCT05441423
Different Implant Positions for Implant Retained Mandibular Overdenture
NCT06055842
Peri Implant Marginal Bone Height and Bone Density
NCT05974215
Clinical Assessment of Computer-assisted PEEK Versus Conventional Titanium Plates on Mandibular Body Fractures
NCT03466190
Assessment of Alveolar Bone Thickness Buccal to Maxillary Anterior and Premolar Teeth in a Sample of Egyptian Population Using CBCT
NCT04553965
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
CBCT imaging of patients with end stage renal failure, undergoing hemo-dialysis
CBCT imaging
CBCT imaging of participants, then take measurement by radiomorphometric indices
control group
CBCT imaging of medically-free participants
CBCT imaging
CBCT imaging of participants, then take measurement by radiomorphometric indices
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBCT imaging
CBCT imaging of participants, then take measurement by radiomorphometric indices
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergone hemo-dialysis, three times/week (in study group)
* Duration of dialysis (≥1 year) (in study group)
* PTH (140-630)
* Age group (18-40 years)
* Mandible
* Free from any other systemic disease affecting the bone quality
* Egyptian population
Exclusion Criteria
* Patients with diabetes, hyperthyroidism, postmenopausal osteoporosis
* Maxilla
* Other language
* Completely Edentulous patients.
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eman mamdouh
Assistant lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eman M Mohamed, MSc
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEBD-CU-2017-05-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.